tiprankstipranks
Trending News
More News >
MediPharm Labs (TSE:LABS)
TSX:LABS
Canadian Market
Advertisement

MediPharm Labs (LABS) Stock Forecast & Price Target

Compare
170 Followers
See the Price Targets and Ratings of:

LABS Financial Forecast

LABS Earnings Forecast

Next quarter’s earnings estimate for LABS is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s EPS was -C$0.01. LABS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year LABS has Performed in-line its overall industry.
Next quarter’s earnings estimate for LABS is C$0.00 with a range of C$0.00 to C$0.00. The previous quarter’s EPS was -C$0.01. LABS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year LABS has Performed in-line its overall industry.

LABS Sales Forecast

Next quarter’s sales forecast for LABS is C$11.82M with a range of C$11.82M to C$11.82M. The previous quarter’s sales results were C$11.45M. LABS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year LABS has Performed in-line its overall industry.
Next quarter’s sales forecast for LABS is C$11.82M with a range of C$11.82M to C$11.82M. The previous quarter’s sales results were C$11.45M. LABS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year LABS has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
No data currently available
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
No data currently available
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

LABS Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
16
17
11
12
10
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
16
17
11
12
10
In the current month, LABS has received 0 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. LABS average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

LABS Stock Forecast FAQ

What is TSE:LABS’s average 12-month price target, according to analysts?
Currently, no data Available
What is TSE:LABS’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TSE:LABS, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TSE:LABS a Buy, Sell or Hold?
      Currently, no data Available
      What is MediPharm Labs’s price target?
      Currently, no data Available
      What do analysts say about MediPharm Labs?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of TSE:LABS?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis